Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.

about

Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection

P2860

Q27728113-FDA6C22E-1394-4225-820E-6BAB1AD2880D

P2860

Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.

Item

http://www.wikidata.org/entity/Q35647771

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Advanced glycation end product ...... ct infection in diabetic mice.

@ast

Advanced glycation end product ...... ct infection in diabetic mice.

@en

type

Item

label

Advanced glycation end product ...... ct infection in diabetic mice.

@ast

Advanced glycation end product ...... ct infection in diabetic mice.

@en

prefLabel

Advanced glycation end product ...... ct infection in diabetic mice.

@ast

Advanced glycation end product ...... ct infection in diabetic mice.

@en

P1476

Advanced glycation end product ...... act infection in diabetic mice

@en

P2093

Cengiz Z Altuntas

http://www.w3.org/2001/XMLSchema#string

Firouz Daneshgari

http://www.w3.org/2001/XMLSchema#string

Fuat Bicer

http://www.w3.org/2001/XMLSchema#string

Guiming Liu

http://www.w3.org/2001/XMLSchema#string

Kenan Izgi

http://www.w3.org/2001/XMLSchema#string

P2860

Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract

Estimating health care-associated infections and deaths in U.S. hospitals, 2002

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Biochemistry and molecular cell biology of diabetic complications

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors

Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection

Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding

Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract.

Bacteria-induced uroplakin signaling mediates bladder response to infection

P31

scholarly article

P356

10.1093/FEMSPD/FTU004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ahmet Ozer

Scott J. Hultgren

P577

2014-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25986378

http://www.w3.org/2001/XMLSchema#string

P932

4444075

http://www.w3.org/2001/XMLSchema#string

Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.

about

P2860

P2860

Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932